Background Oral potentially malignant disorders (OPMDs) occur in up to 4%–5% of the
population, of which oral leukoplakia (OL) is the most common subtype. Predicting high‐risk …

In clinical practice, cisplatin is the most commonly used chemotherapy drug to treat a range
of malignancies. Severe ROS-regulated nephrotoxicity, however, restricts its applicability …

This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in
oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical …

Background Proliferative verrucous leukoplakia (PVL) is a rare and enigmatic oral
potentially malignant disorder which almost invariably results in oral squamous cell …

Background Oral leukoplakia (OL) is an unfavorable oral disease often resistant to therapy.
To this end, cold physical plasma technology was explored as a novel therapeutic agent in …

Discussion Leukoplakia is classified into two types: homogeneous (flat white lesion) and
non-homogeneous (speckled, nodular and verrucous leukoplakia),[1] the latter consistent …

O carcinoma espinocelular (CEC) da região de cabeça e pescoço (CECCP) é um grupo
heterogêneo de neoplasias malignas se originando da pele e mucosas, representando …